Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

593
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
593
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

676
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
676
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

394
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
394
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

1.6K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.6K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

967
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
967
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

928
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
928

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2-Furoic acid associated with the infection of nematodes by <i>Dactylellina haptotyla</i> and its biocontrol potential on plant root-knot nematodes.

Microbiology spectrum·2023
Same author

Fecal calprotectin as an indicator in risk stratification of pouchitis following ileal pouch-anal anastomosis for ulcerative colitis.

Annals of medicine·2023
Same author

Identification and Mechanism of Action of the Global Secondary Metabolism Regulator SaraC in <i>Stereum hirsutum</i>.

Microbiology spectrum·2022
Same author

Case Report: An Unusual Case of Pulmonary Metastatic Adenocarcinoma From Low-Grade Appendiceal Mucinous Neoplasms.

Frontiers in oncology·2022
Same author

Identification of Nematicidal Metabolites from <i>Purpureocillium lavendulum</i>.

Microorganisms·2022
Same author

Pathogenicity and Metabolites of <i>Purpureocillium lavendulum</i> YMF1.00683 against <i>Meloidogyne incognita</i>.

Pathogens (Basel, Switzerland)·2022

Related Experiment Video

Updated: Dec 8, 2025

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

730

Gastroduodenitis associated with ulcerative colitis: A case report.

Ye Yang1, Chun-Qiang Li2, Wu-Jie Chen1

  • 1Department of Gastroenterology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo 315000, Zhejiang Province, China.

World Journal of Clinical Cases
|September 21, 2020
PubMed
Summary

This case study highlights rare upper gastrointestinal involvement in ulcerative colitis (UC), presenting as gastroduodenitis. Early diagnosis and treatment with pentasa led to complete remission in a patient with UC and Klippel-Trenaunay syndrome.

Keywords:
Abdominal painCase reportDuodenitisGastritisGastroduodenitisUlcerative colitis

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.5K
Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.4K

Related Experiment Videos

Last Updated: Dec 8, 2025

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

730
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.5K
Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.4K

Area of Science:

  • Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Case Studies

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease primarily affecting the large intestine.
  • While typically limited to the colon, recent reports indicate UC can involve the upper gastrointestinal tract, including the stomach and duodenum.
  • Gastroduodenitis associated with UC (GDUC) represents a rare manifestation requiring careful differential diagnosis.

Observation:

  • A 25-year-old male with Klippel-Trenaunay syndrome presented with bloody stool and epigastric pain.
  • Colonoscopy revealed superficial ulcers and bleeding; gastroscopy showed diffuse edema, ulcers, and friable mucosa in the stomach and duodenum.
  • These upper GI findings were similar in appearance to rectal lesions characteristic of UC.

Findings:

  • A diagnosis of gastroduodenitis associated with ulcerative colitis (GDUC) was established after excluding other conditions.
  • The patient received standardized treatment with pentasa (4.8 g/day), a 5-aminosalicylic acid formulation.
  • Complete symptom remission was achieved within 0.5 months, with no recurrence observed for 26 months.

Implications:

  • The occurrence of upper gastrointestinal lesions in UC is uncommon but significant.
  • This case underscores the importance of considering a broad differential diagnosis in IBD patients with upper GI symptoms.
  • Further research into the etiology and pathogenesis of GDUC may provide new insights into UC.